In conclusion, we demonstrated that higher disease activity was associated with increased neuronal damage assessed by plasma NfL levels, and that the lupus phenotypes with more disease activity over time or persistently high serum IFN-α levels were associated with long-term structural and functional effects on the brain according to MRI alterations and cognitive dysfunction upon testing. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.